Bristol-Myers Squibb Company (BMY)

33.09 +0.10  +0.30%  May 25, 11:00PM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

Bristol-Myers Squibb Company Tangible Common Equity Ratio: 22.27%

Get Interactive Chart for

View BMY Tangible Common Equity Ratio with YCharts Pro.




Start My 14-Day Free Trial We respect your privacy. We will never share your email address.
document.write('');

Access these YCharts Pro features:

  • Export any data you want
  • Save any chart as an image
  • Utilize advanced screener power
  • View 30 years of financial history
  • over 90 advanced calculations
  • Enjoy an advertising free experience
and much more...

BMY Tangible Common Equity Ratio Rankings

Overall 64th percentile 1575 of 4385
Sector 71st percentile 142 of 504 in Healthcare
Industry 60th percentile 10 of 25 in Drug Manufacturers - Major

BMY Tangible Common Equity Ratio Range, Past 5 Years

Minimum 20.47% Jun 2007
Maximum 33.62% Jun 2009
Average 28.28%

About Tangible Common Equity Ratio

The tangible common equity (TCE) ratio is a useful number to gauge leverage of a financial firm. Specifically, it answers the question: "How much can the value of a bank's assets fall before the entire value of tangible* common equity is wiped out?"

For example, assume a bank as a TCE ratio of 5%. If the value of all of the banks assets fell by 5%, theoretically stockholders would no longer have a claim on the bank's tangible assets.

Another way of thinking about the TCE ratio of 5% is that the remaining 95% of the bank's tangible assets have been purchased using loaned funds that the bank must repay.

This ratio is worth spending time with. Once investors understand its implications, they rarely look at banking businesses the same way.

* The word tangible, in accounting, essentially means anything that can be touched or traded. Cash, buildings, accounts receivable, inventories and stock holdings of a business are all tangible assets. Trade secrets, patents, copyrights, and goodwill are not tangible assets, even though they may have value.
Learn More

You may also be interested in these BMY related companies

Display in Live Stream: Done
Options

BMY News

Is This Biotech's Best Stock?
May 27, 9:09AM Fool
@biotech $CYCC $CELG $BMY $REGN $PFE #ASCO12 checklist **All good names. I only focus on under $4 stocks though. Bouncier! ;=)
about 3 days ago by Urbane_Gorilla
Finding a Pathway to Approval
May 24, 2:53PM Fool
Best US dividend stocks with growing cash flow http://stks.co/3y55 $PBI $EEP $NNN $PBCT $PAA $AEP $VVC $MRK $UVV $PAYX $NUE $BMY $HI $SWY
about 4 days ago by ScottAdams_Edit
Is Bristol a Buy Post-Plavix
May 23, 5:38PM Fool
RT @ianestepan $CLDX if this data was from $BMY,$ONXX,$MDVN,$DNA or $PFE - people would be soooooo excited....
about 4 days ago by N0M0NEY_N0H0NEY
$BMY got on this junje calls
about 5 days ago by selectstock
How to Play an Arena Delay
May 22, 3:39PM Fool
watchin OEX Stocks that were sold the most during sell programs: $MRK, $LOW, $EXC, $JPM, $MS, $HNZ, $WAG, $BMY, $PEP, $PG, $BAC, $CL, $AMGN
about 5 days ago by mrtopstep
June ASCO biotechs to watch : $ARQL $GALE $ONTY big pharma I am sure is watching them as well like $MRK $BMY $PFE
about 9 days ago by EPS_MomentuM
Generic Versions of Plavix Get FDA Approval
May 18, 11:46AM Investor Place
Gilead Sciences’ HIV Drugs Clear a Hurdle
May 17, 10:00AM Investor Place
A Big Trade on Big Pharma
May 17, 2:30AM Investor Place
@jimcramer how does that affect $BMY ?
about 11 days ago by kawfeeman
News & Trends
May 15, 10:58PM The Wall Street Journal
AstraZeneca among suitors eyeing Amylin
May 15, 2:46PM Financial Times
News related to $BMY, currently +0.5% since open: 'Bristol-Myers says FDA clears Mass. plant' http://stks.co/3q1B
about 12 days ago by TradeBot
Six Suitors Join $BMY in Considering a Bid for $AMLN http://stks.co/3psG
about 12 days ago by abubnic
The Drama Continues At $AMLN: Takeover Still Likely. $BMY $LLY $SNY http://stks.co/3prL
about 12 days ago by abubnic
A Step Closer to Quadrific Sales
May 14, 10:39PM Fool
$BMY is near a strong 3 month support level
about 14 days ago by MPI
NR7 (EOD): Potential bullish NR7. Entry: 33.31. First Target: 34.00. $BMY http://chart.ly/qwxxeih
about 15 days ago by jackdamn
$BMY Ipilimumab,also known as MDX-010 or MDX-101 $DNDN Provenge along with $ARNA and $VVUS have been and are my Phamas for the next yr
about 16 days ago by selectstock
This Biotech Is No One-Trick Pony
May 10, 2:10PM Fool
Huf Post: Two Drugs Harness Immune System To Fight Cancer. http://stks.co/3iDa $DNDN $BMY $AZN $ONTY $GSK
about 20 days ago by abubnic
Listen to $BMY Bristol-Myers Squibb at Deutsche Bank AG Health Care Conference - live at 10:40 AM, ondemand after - http://stks.co/3hTs
about 21 days ago by earningscast
Best Yielding Large Cap Healthcare Stocks + http://stks.co/3cMJ + $JNJ $PFE $NVS $MRK $GSK $SNY $NVO $UNH $BMY $TEVA $MDT $BAX $AGN $SYK
about 26 days ago by DividendYield
@russwm thanks working hard here. above 34 is a desc trend break + above 10day. needs to hold 50day $BMY http://chart.ly/mghypbo
about 26 days ago by TraderNewburgh
@TraderNewburgh I would love to hear your thoughts on $BMY in the short/medium term, if you have the time. Love your videos.
about 26 days ago by russwm
Listen to $BMY Bristol-Myers Squibb Annual Meeting of Stockholders - live at 10:00 AM, ondemand after - http://stks.co/3bIu
about 27 days ago by earningscast
http://stks.co/3XIO Health Care Report Take A Look $FURX $BMY $AMLN
about 31 days ago by Stockmarketman2
$BMY filed latest Quarterly Report http://stks.co/3X1p
about 31 days ago by MarketBrief

Recent Quotes

Symbol Price Chg Chg % Market Cap
BMY 33.09 +0.10 +0.30% 55.84B
BMTI 2.43 +0.02 +0.83% 68.36M
BMRN 38.64 +0.13 +0.34% 4.468B
BMJ 0.93 +0.00 +0.00%
BMI 36.69 -0.25 -0.68% 550.35M
BMC 43.69 +0.72 +1.68% 7.175B
BMA 13.46 -0.33 -2.39% 785.12M
BLX 19.14 -0.08 -0.42% 540.90M
BLV 93.83 +0.41 +0.44%
BLTI 2.42 +0.06 +2.54% 74.27M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close